Trademark Attorney / Law Firm

Steven P. Otillar – Trademark Portfolio

Steven P. Otillar specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 8 of 13 total filings concentrated in this category. The practice also covers Class 35 (Advertising & Business) along with 5 other Nice Classification classes. Currently, 0 trademarks are registered.

13 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Steven P. Otillar's trademark practice covers 5 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

25
Clothing (1 filing)

Clothing, footwear, headgear

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

43
Hotels & Restaurants (1 filing)

Services for providing food and drink; temporary accommodation

Frequently Asked Questions

How many trademark applications has Steven P. Otillar filed?

Steven P. Otillar has filed 13 trademark applications with the United States Patent and Trademark Office (USPTO).

What trademark classes does Steven P. Otillar specialize in?

Steven P. Otillar has filed trademarks across 5 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 25 (Clothing), Class 42 (Computer & Scientific), Class 43 (Hotels & Restaurants). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Steven P. Otillar's trademark registration success rate?

Steven P. Otillar has a 0% trademark registration rate, with 0 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.